Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.
about
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia.
P2860
Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Prognostic impact of pretreatm ...... a of minimal residual disease.
@en
Prognostic impact of pretreatm ...... a of minimal residual disease.
@nl
type
label
Prognostic impact of pretreatm ...... a of minimal residual disease.
@en
Prognostic impact of pretreatm ...... a of minimal residual disease.
@nl
prefLabel
Prognostic impact of pretreatm ...... a of minimal residual disease.
@en
Prognostic impact of pretreatm ...... a of minimal residual disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prognostic impact of pretreatm ...... a of minimal residual disease.
@en
P2093
C Cameron Yin
Deborah Thomas
Ghayas C Issa
Issa Khouri
Naval Daver
Nitin Jain
Partow Kebriaei
Richard E Champlin
Susan M O'Brien
Tapan M Kadia
P2860
P304
P356
10.1002/CNCR.30376
P407
P50
P577
2016-10-03T00:00:00Z